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Editorial on the Research Topic
Radiation and the Immune System: Current Knowledge and Future Perspectives
At present, the opinions about the interaction between ionizing radiation and the immune system 
are largely controversial. For long, high-dose ionizing radiation was considered as net immune sup-
pressing mainly due to the exquisite radiosensitivity of the lymphoid system. While this increased 
radiosensitivity cannot be contested, a rapidly growing number of scientific publications have 
demonstrated a very heterogeneous quantitative and functional response of the different com-
ponents of the immune system to radiation (1–3). A major milestone was achieved in the field 
of onco-immunology, where it has been shown that local tumor irradiation could modulate the 
immunogenicity of tumor cells and also the antitumor immune responsiveness both locally in the 
tumor microenvironment and at a systemic level (4–6). This latter observation opened the gate 
for studies exploring optimal combinations of radiotherapy (RT) and immunotherapy in order to 
achieve a synergistic effect.
It was additionally recognized that some of the radiation-induced late side effects are of immune 
and inflammatory nature. At present, one of the most studied fields of research in radiation biol-
ogy is focused around the biological effects of low doses, where the observed pathophysiological 
endpoints are due to mechanisms other than radiation-induced direct cell killing. Such mechanisms 
are for example radiation-induced bystander effects or abscopal effects, which by sharing common 
mediators with various immunological signaling processes, are most probably immune-mediated.
The multitude of studies investigating the interactions between ionizing radiation and the 
immune system lead to the emergence of a new, highly interdisciplinary scientific field called radio-
immunobiology, with the potential to induce a paradigm change in this area and to achieve direct 
clinical applications within a relatively short term. Scientific primary and overview papers collected 
in the present Research Topic aim to give an up-to-date state of the art of the complex interactions 
between the immune system and ionizing radiation while highlighting future perspectives as well. 
This paradigm change is nicely illustrated in the review by Schaue, who gives a comprehensive 
historical overview regarding the interaction between ionizing radiation in general and RT, in 
particular, and the immune system.
Although the cell autonomous effects of ionizing radiation are well established, there is nowadays 
growing evidence that intercellular communication plays a major role in the outcome of radiation 
exposure at the tissue level. This is especially true in cancer therapy. Radiation exposure aims at 
killing tumor cells, but efficient tumor control/eradication also requires the activation of the 
immune system. The tumor microenvironment indeed contains various subsets of immune cells, 
both myeloid cells and lymphocytes. Among the myeloid cells, myeloid-derived suppressor cells 
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and tumor-associated macrophages provide a supportive envi-
ronment for tumor growth, in part by suppressing the activity of 
cytotoxic T cells. Wennerberg et al. summarize further immune 
suppressive properties of radiation on the cellular and molecular 
level besides the impact of radiation on expression of inhibitory 
immune checkpoint molecules such as PD-L1. The impact of RT 
and radiochemotherapy (RCT) on the latter on tumor cells of dif-
ferent tumor entities is the focus of the research article by Derer 
et al. They show that, in particular, RCT increases the expression 
of PD-L1 on melanoma and glioblastoma cells. This demands 
radioimmunotherapies (RIT) to counteract radiation-induced 
immune suppression. For the design of beneficial RIT, many 
additional parameters have to be taken into account. What is the 
best radiation dose and radiation quality? Ebner et al. review the 
unique biological and physical benefits of particle irradiation that 
may be superior in some aspects for the generation of systemic 
radiation-induced immune-mediated effects. Besides the radia-
tion quality, the dose and the chronological sequence of immune 
cell infiltration into the tumor has to be kept in mind. Frey et al. 
present data on timely restricted immune cell infiltration fol-
lowing hypofractionated radiation. Cytotoxic T cells follow the 
antigen-presenting cells and are present for only 2 days. Here, re-
irradiation of the tumor should be revisited to spare the immune 
cells, and boosting of the immune system at this time point could 
be particularly effective. Since the inflamed microenvironment 
of tumors impacts on growth and progression, several articles 
deal with modulation of inflammation by radiation. Rödel et al. 
review radiation-induced mechanisms contributing to a modula-
tion of proliferative and inflammatory processes. They focus on 
summarizing innovative concepts of treating hyperproliferative 
diseases by low and moderate doses of ionizing radiation. Since 
inflammatory events and bone metabolism are interconnected, 
radiation also impacts on bone turnover. Cucu et al. demonstrate 
in serum samples of patients who were exposed to very low doses 
of alpha-irradiation in radon spa that collagen fragments (in 
particular CTX-I) are decreased after radiation exposure. This 
suggests a reduced bone resorption by osteoclasts. The interleu-
kin IL-33 has been described as an intracellular alarmin being 
involved in many inflammatory processes. Kurow et al. revealed 
that the release of full length IL33 in the damaged tissue does 
exacerbate radiation-induced skin reactions.
Thus, radiation acts and modulates immune reactions, includ-
ing inflammation, at various levels and in all tissues. Immune cells 
and, in particular, lymphocytes are key players in the response 
against radiation-modified tumor cells. In order to highlight 
transcriptionally responsive genes, which play a role in the 
inflammation response, Manning et al. monitored the expression 
of about 250 genes associated with the inflammation response 
over the course of the RT in blood of patients with endometrial 
or head and neck cancer. Some of these inflammation-related 
genes could be promising biomarkers of radiation exposure 
and susceptibility to radiation-induced toxicity. Radiation-
induced inflammatory reactions are also heavily involved in the 
development of radiation-related side effects in various tissues. 
Several papers within this research topic specifically focus on 
this aspect. Wirsdörfer and Jendrossek summarize radiation-
dependent mechanism of acute and chronic environmental lung 
changes following thoracic irradiation. Acheva et al. present new 
data regarding the mechanism of RT-induced skin side effects 
focusing on the role of NFκB and Cox-2 in the generation of 
pro-inflammatory signals. Morini et al. investigate the impact of 
ionizing radiation on the permeability of the intestinal barrier 
in the context of colorectal cancer and show that several of the 
involved mechanisms are immune- and inflammation-related. 
Lumniczky et al. review radiation-induced immune and inflam-
matory reactions in the brain, highlighting potential mechanisms 
how these interactions can lead to long-lasting functional altera-
tions and the development of cognitive impairment. Amelioration 
of chronic inflammation, induction of acute damage (e.g., tumor 
cell necrosis/danger), and counter-balancing the tumor- and 
radiation-derived immune suppression can in sum result not 
only in specific and long-lasting antitumor immunity but also in 
less frequent or less severe side effects and lead to an increased 
resistance toward radiation. This is highlighted in the paper by 
Singh et al. who show that the radioprotective effect of two well-
characterized antioxidant compounds (podophyllin and rutin) is 
mainly immune-mediated.
Therefore, one of the beneficial effects of RT is, in some 
instance, to shift the equilibrium toward immune activation. For 
this, additional immunotherapy is mostly needed.
As discussed in their review by Wu et al., in addition to the 
direct effects of radiation on the different immune cell subsets, 
a key event in the (re)-activation of tumor-associated immune 
cells is the type of tumor cell death induced by radiation, as 
apoptosis, necrosis, autophagic cell death, and mitotic catas-
trophe differ in their ability to reverse immunosuppression and 
elicit these tumor-specific immune responses. As the release of 
metabolites such as inosine by dying or dead tumor cells can on 
the opposite stimulate the outgrowth of rare spared tumor cells 
(Chen et al.), the net outcome of radiation-therapy will depend 
on the competition between immunogenic and pro-tumorigenic 
events. Vaupel and Multhoff in particularly focus in their com-
mentary on the role of adenosine as a consequence of hypoxia as 
metabolic immune checkpoint in the tumor microenvironment. 
Furthermore, the outcome of radiation exposure depends not 
only on the type of tumor and its microenvironment but also 
on the dose and quality of radiation and the irradiation scheme 
used. Even if more studies are required, especially on the effects 
of protons and carbon ions exposure (summarized by Ebner 
et al.), it is clear that these parameters can modulate the differ-
ent aspects of the intercellular communication in the irradiated 
tumor microenvironment (reviewed by Diegeler and Hellweg). 
In addition to their direct effects on mature lymphocytes and 
T lymphocyte response to irradiation-induced bystander signals, 
ionizing radiation also affects T lymphocyte development. This 
aspect of the interactions between radiation and the immune 
system is addressed by Calvo-Asensio et al. in a research article 
where they analyze the response of thymic epithelial cells (TECs) 
to radiation exposure in vitro and ex vivo. TEC represent less than 
1% of the cells found in the thymus, but these highly specialized 
cells are essential for the generation of mature, functional T lym-
phocytes. Although they are quite radio-resistant, the expression 
of many genes essential for proper T  lymphocyte development 
is de-regulated after exposure. These effects probably contribute 
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to the profound T cell deficiency observed in patient exposed to 
radiation in the frame of the conditioning regime before bone-
marrow transplantation.
Last but not least, a special focus is placed on the investiga-
tion of low-dose radiation-induced immune mechanisms and 
inflammatory reactions. Szatmári et al. demonstrate in an in vivo 
experimental setup that extracellular vesicles are responsible 
for mediating certain radiation-induced bystander effects in 
the bone marrow. Erbeldinger et  al. present a new method by 
which the effect of ionizing radiation on endothelial cells can 
be investigated in  vitro where hemodynamical parameters are 
much closer to physiological conditions than using conventional 
cell cultures. In this system, they show that both low energy and 
heavily charged particles induce altered adhesion of peripheral 
blood lymphocytes and activation of the NFκB pathway. With 
the perspective of space travel and a Mars mission in a reason-
ably near future, the impact of cosmic radiation becomes a 
particularly important health problem, and the potential effects 
of charged heavy particles on the immune system and their long-
lasting health consequences will need to be addressed. Since 
heavy particles are increasingly used in therapeutic radiation as 
well, their interaction with the immune system, in the view of a 
potential combination with immunotherapy should be carefully 
studied. These issues are dealt with in detail in the mini-review 
by Fernandez-Gonzalo et al.
Thus, the editors of the Research Topic hope that this collec-
tion of articles is able to give a good overview of the complex 
and often contradictory nature of the interactions between 
ionizing radiation and the immune system. Our intention was 
also to draw the attention of the non-radiobiological scientific 
community on these complex interactions and to highlight the 
fact that ionizing radiation is by far more than purely an immune 
suppressing agent. The increasing penetrance of low-dose ioniz-
ing radiation both through medical diagnostic or environmental 
sources or during cosmic travel in the population is becoming a 
major epidemiological concern world-wide and the mechanisms 
how low-dose radiation act and the potential long-term health 
consequences need to be thoroughly investigated.
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